Skip to content

Clinical trials

Phase 2/3 Epilepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 2/3 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20082
20101
20132
20161
20171
20211
20222
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Unknown status4
Completed3
Active, not recruiting2
Suspended1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biohaven Therapeutics Ltd.3
Columbia University1
Hospital do Coracao1
Katarzyna Kotulska1
M.D. Anderson Cancer Center1
NMT Medical1
Sohag University1
The Canadian College of Naturopathic Medicine1
The Second Hospital of Nanjing Medical University1
UCB BIOSCIENCES, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy16
Seizures7
Drug Resistant Epilepsy4
Epilepsies, Partial3
Epilepsy, Generalized2
Delirium1
Encephalitis1
Epilepsy, Absence1
Foramen Ovale, Patent1
Headache1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.